Seratrodast

塞曲司特

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameSeratrodast
Drug Alias NameSerabenast塞曲斯特塞拉司特seratrodastumseratrodast +[11] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionThromboxane A2 receptor antagonists
TargetsThromboxane A2 receptor
Therapy Area/IndicationsAsthma
Global Approved IndicationsAsthma
Approved Indications in ChinaAsthma
Original Approved Country/TerritoryJapan
Original Approved Date1995/01/01
Country/TerritoryMainland ChinaJapan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesTakeda Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesChangzhou Watson Pharmaceuticals Co Ltd
Inactive CompaniesN/A
Active IndicationsAsthma
Inactive IndicationsN/A

Other Information

ATC CodeR03DX06
Related LinksWikipediaKEGG